Global HIV, Hepatitis and STIs Programmes
The Department of Global HIV, Hepatitis and Sexually Transmitted Infections Programmes leads the development and implementation of the global health sector strategy on the elimination of the diseases as public health threats.

Publications

All →
Implementing the global health sector strategies on HIV, viral hepatitis and sexually transmitted infections, 2022–2030: Report on progress and gaps 2024, second edition

This report is the first of a series of biennial progress reports on the implementation of the Global health sector strategies on, respectively, HIV, viral...

Guidelines for HIV post-exposure prophylaxis

Despite advancements in testing and treatment, over one million people became infected with HIV in 2022. This warrants a need for a revitalized focus on...

WHO global research 
priorities for sexually 
transmitted infections

Sexually transmitted infections (STIs) are widespread globally and negatively affect sexual and reproductive health. Gaps in evidence and in available...

Consolidated guidelines on differentiated HIV testing services

These guidelines outline a public health approach to strengthening and expanding HIV testing services (HTS). They present and discuss key updates...

Framework for monitoring sexually transmitted infections and strengthening surveillance

This publication has been developed to provide a national framework for monitoring the health sector’s response to sexually transmitted infections...

Updated recommendations for the treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Treponema pallidum (‎syphilis)‎ and new recommendations on syphilis testing and partner services

The objectives of these present guidelines are: to provide updated evidence-informed guidance on treating infections caused by N. gonorrhoeae and C. trachomatis...

Fourth Consultation of the Regional Expert Panel for Verification of Hepatitis B Control in the South-East Asia Region, Mumbai, India 16–18 January 2024

Hepatitis B control had gained momentum in the WHO South-East (SE) Asia Region as its public health burden had been recognized even prior to the COVID-19...

Recommendations for the treatment of Trichomonas vaginalis, Mycoplasma genitalium, Candida albicans, bacterial vaginosis and human papillomavirus (‎anogenital warts)‎

These guidelines focus on the treatment for infections caused by Trichomonas vaginalis, Mycoplasma genitalium and Candida albicans, and treatment for the...